Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Day One
Day one of the meeting featured sessions on pre-MPN, atypical MPNs and inflammation; MPN subtypes; unmet therapeutic needs in treatment of indolent MPNs, and a session covering treating patients with myelofibrosis.
Rafael Bejar, MD, PhD
Angela Fleischman, MD
Ronald Hoffman, MD
Nicole Kucine, MD, MS
Jerry Spivak, MD
Raajit Rampal, MD, PhD
Prithviraj Bose, MD
Jerry Spivak, MD
Rafael Bejar, MD, PhD
Angela Fleischman, MD
Ronald Hoffman, MD
Nicole Kucine, MD, MS
Day Two
Day two of the meeting featured sessions on COVID-19; rare and overlap syndromes; novel pathways and targets in MPNs; interferons, and a session covering SCT and accelerated/blast phase MPN.
Rafael Bejar, MD, PhD
Angela Fleischman, MD
Ronald Hoffman, MD
Nicole Kucine, MD, MS
Jerry Spivak, MD
Raajit Rampal, MD, PhD
Prithviraj Bose, MD
Jerry Spivak, MD
Rafael Bejar, MD, PhD
Angela Fleischman, MD
Ronald Hoffman, MD
Nicole Kucine, MD, MS
Jerry Spivak, MD
Raajit Rampal, MD, PhD
Check out our latest MPN content!
Our myeloproliferative neoplasms (MPN) channel examines the latest updates in MPNs.
With content featuring expert interviews from major international congresses and news by subtype, this is one for your bookmarks!
To keep updated on all the latest in MPNs and beyond, subscribe to our newsletter here.
